Observational studyHepatology international2026
Cirrhotic cardiomyopathy in children with biliary atresia and genetic intrahepatic cholestasis: clinical course and outcomes.
Observational study in Hepatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Terlipressin in paediatric hepatorenal syndrome-acute kidney injury (HRS-AKI).Pediatric nephrology (Berlin, Germany) · 2026Review
- Insights in a prospective investigation of cardiomyopathy in children with biliary atresia and hereditary intrahepatic cholestasis: focus on diagnosis, survival analysis, and bias control.Hepatology international · 2026Article
- Comment on "Cirrhotic cardiomyopathy in children with biliary atresia and genetic intrahepatic cholestasis: clinical course and outcomes".Hepatology international · 2026Article
- Comment on "Cirrhotic cardiomyopathy in children with biliary atresia and genetic intrahepatic cholestasis: clinical course and outcomes".Hepatology international · 2026Article
- Comment on "Cirrhotic cardiomyopathy in children with biliary atresia and genetic intrahepatic cholestasis: clinical course and outcomes".Hepatology international · 2026Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesCirrhotic cardiomyopathy (CCM) is an under recognized entity in children. The present study aimed to explore the prevalence and natural history of CCM and its impact on outcomes among children with biliary atresia (BA) and genetic intrahepatic cholestasis (GIC).
methodsThis was a prospective observational study. All children aged 0-18 years and diagnosed with either BA or GIC were included. Relevant clinical and biochemical parameters were recorded and transthoracic echocardiography was done. Left ventricular mass index (LVMI) ≥ 95 g/m
resultsEighty nine children were included in the study, 64 with BA and 25 with GIC. Prevalence of CCM in children with BA and GIC were 53.13% and 48% respectively. LVMI (g/m
conclusionsCCM is prevalent in almost half of patients with BA and GIC and is associated with decreased NLS and OS. Serum bile acids were significantly higher in children with CCM.
Indexed as
Identifiers
41108489What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.